Navigation Links
Vanda Pharmaceuticals Reports First Quarter 2013 Results
Date:5/9/2013

gement team as Senior Vice President, Chief Medical Officer.  He had assumed the role of Vanda's acting Chief Medical Officer in October 2012.  Dr. Baroldi previously served as Vanda's Senior Vice President and Chief Medical Officer from July 2006 through January 2009.
He has also served in senior clinical development positions at Galileo Research, Supernus Pharmaceuticals, Chiesi Famaceutici SpA, and Novartis.

2013 FINANCIAL GUIDANCE2013 financial guidance assumes a mid-year NDA submission for tasimelteon for Non-24 is accepted by the FDA for Standard Review.  2013 expenses are expected to reflect lower research and development spending as compared to 2012 and an increase in commercial spending that is commensurate to progress with the tasimelteon NDA filing.

  • Full year 2013 decrease in Cash is expected to be between $45.0 and $50.0 million, compared to $47.5 million for 2012.
  • Total 2013 operating expenses are expected to be between $57.0 and $62.0 million.  This includes Fanapt® intangible asset amortization of $1.5 million and $4.0 to $6.0 million of non-cash stock based compensation.
    Total 2012 operating expenses were $61.0 million.
  • 2013 operating expense guidance assumes $4.3 million in milestone payments due upon the acceptance by the FDA of a tasimelteon NDA submission and $3.0 to $4.0 million in NDA filing-related expenses.
  • CONFERENCE CALLVanda has scheduled a conference call for today, Thursday, May 9, 2013, at 10:00 AM ET.  During the call, Vanda's management will discuss the first quarter 2013 financial results and other corporate activities.  Investors can call 1-877-280-4962 (domestic) and 1-857-244-7319 (international) and use passcode 32610810.  A replay of the call will be available beginning Thursday, May 9, 2013 at 12:00 PM ET and will be accessible until Thursday, May 16, 2013, at 5:00 PM ET.  The replay call-in number is 1-888-286-8010 for domestic call
    '/>"/>

    SOURCE Vanda Pharmaceuticals Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related biology technology :

    1. Vanda Pharmaceuticals Appoints Dr. Paolo Baroldi As Chief Medical Officer
    2. Nieuwe behandeloptie vandaag geïntroduceerd voor artsen die patiënten behandelen met veelvuldig recidiverend of refractair agressief B-cel-non-hodgkinlymfoom
    3. Vanda Pharmaceuticals to Present at the Lazard Healthcare Conference
    4. Questcor Pharmaceuticals to Present at Bank of America Merrill Lynch 2013 Healthcare Conference
    5. Adamis Pharmaceuticals CEO Provides Update for Shareholders
    6. Cadence Pharmaceuticals Reports First Quarter 2013 Financial Results
    7. Valeant Pharmaceuticals Announces Extension of the Expiration Date for Its Previously Announced Tender Offer for All Outstanding Shares of Common Stock of Obagi Medical Products, Inc.
    8. VentiRx Pharmaceuticals Appoints James Kyle Bryan, M.D. as Chief Medical Officer
    9. Aurigenes Collaboration Programs with Endo Pharmaceuticals Reach Important Milestones
    10. Next Silicon Valley BioTalks Tackles “Is EDC Becoming a Commodity?” at Onyx Pharmaceuticals HQ
    11. Global Nuclear Medicine / Radiopharmaceuticals Market worth $5.55 Billion by 2017
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/28/2015)... ... 2015 , ... Proove Biosciences , a commercial and ... Intervention Society’ s 23rd Annual Scientific Meeting (ASM). The ASM event took ... on evidence-based research and clinical application, the event gathered industry thought leaders to ...
    (Date:8/28/2015)... ... August 28, 2015 , ... Riordan-McKenna Institute ... DO, announced today that the use of sterile, dehydrated amniotic tissue AlphaPATCH™ developed ... an otherwise non-healing surgical knee wound. , The case involved a 78-year-old male, ...
    (Date:8/27/2015)... ... August 27, 2015 , ... Capital Edge Consulting , a nationwide ... pleased to announce their ranking as one of the top 5000 companies listed on ... companies across the nation. , “It is truly an honor to be recognized as ...
    (Date:8/27/2015)... The National Necrotizing Fasciitis Foundation ... by doctors at Vanderbilt University Hospital in ... and Dr. John Crew , director of the ... Center in Daly City, CA. ... pioneered by Dr. Crew, that had previously saved the ...
    Breaking Biology Technology:Proove Biosciences Presents New Research Study at the International Spine Intervention Society’s Annual Scientific Meeting 2Proove Biosciences Presents New Research Study at the International Spine Intervention Society’s Annual Scientific Meeting 3Proove Biosciences Presents New Research Study at the International Spine Intervention Society’s Annual Scientific Meeting 4Dallas-Fort Worth Stem Cell Researchers Use Amniotic Tissue To Successfully Treat Non-Healing Surgical Wound 2Dallas-Fort Worth Stem Cell Researchers Use Amniotic Tissue To Successfully Treat Non-Healing Surgical Wound 3Dallas-Fort Worth Stem Cell Researchers Use Amniotic Tissue To Successfully Treat Non-Healing Surgical Wound 4Capital Edge Consulting Makes Inc. 5000 List of America’s Fastest-Growing Private Companies 2Capital Edge Consulting Makes Inc. 5000 List of America’s Fastest-Growing Private Companies 3Patient's Life and Eyes Saved from Gruesome Flesh-Eating Infection Consuming Her Face 2Patient's Life and Eyes Saved from Gruesome Flesh-Eating Infection Consuming Her Face 3
    ... 20, 2011 SomaGenics, Inc., a biotechnology company specializing ... of RNA interference (RNAi) therapeutics against Hepatitis C virus ... SomaGenics, along with its collaborators at Tekmira Pharmaceuticals ... "Synthetic Short shRNAs are Potent Inhibitors of Hepatitis C ...
    ... Sept. 20, 2011 Isaac Eliaz, M.D. L.A.c, M.S., ... in prevention and treatment of breast cancer at The ... Capitol Hill and Congressional Reception . The annual event ... cancer non-profit organization whose mission is to "educate, advocate ...
    ... , New York, NYDATE TK, 2011Columbia Engineering researchers have ... blood-brain barrier (BBB) and deliver drugs safely and noninvasively. ... pulses, which can inflict collateral damage, were required. But ... that extremely short pulses of ultrasound waves can open ...
    Cached Biology Technology:SomaGenics' sshRNA Technology Demonstrates Efficacy of RNAi Against Hepatitis C Virus 2SomaGenics' sshRNA Technology Demonstrates Efficacy of RNAi Against Hepatitis C Virus 3Dr. Isaac Eliaz Gives Keynote Address at Annual Congressional Cancer Reception 2Dr. Isaac Eliaz Gives Keynote Address at Annual Congressional Cancer Reception 3Engineers use short ultrasound pulses to reach neurons through blood-brain barrier 2
    (Date:8/24/2015)... , August 24, 2015 The ... ,s largest biometrics manufacturer DERMALOG and its customized solutions ... "2015 African Biometrics Company of the Year Award". DERMALOG is ... Nigeria .   -Cross reference: Picture is ... - On Thursday evening, in ...
    (Date:8/19/2015)... , Aug. 19, 2015  VOXX International ... it has entered into a Definitive Agreement to ... of iris authentication market leader EyeLock through an ... will have a controlling interest in the acquiring ... to completion of due diligence.  Expanding on its ...
    (Date:8/12/2015)... Florida , August 12, 2015 ... pace of mobile payment innovation and advanced biometrics technology ... replace the way consumers rely on using their credit ... with reinventing the future for payment services led by ... NXTD ), :  Google, Inc. (NASDAQ: GOOG ...
    Breaking Biology News(10 mins):Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 2Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 2VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 4VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 5Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 2Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 3Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 4Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 5Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 6
    ... a part of their eggs on their neighbours. Scientists of ... in every fifth nest there is one egg that is ... in a very well-targeted way: eggs are being placed in ... (online publication in Animal Behaviour , April 15, 2010). ...
    ... 2010 Energy in, energy out, it,s the basic equation ... two thirds of Americans classified as overweight or obese1, a ... of Nutrition Education and Behavior examines how motivation might ... Researchers at the University of Kentucky and University of ...
    ... Basque Neiker-Tecnalia technological centre, in collaboration with the Faculty ... (UPV/EHU), has demonstrated the benefit of alperujo ... during periods when grazing is not available. The analyses ... (a sub-product of the olive obtained after milling and ...
    Cached Biology News:Cuckoo chicks in zebra finches 2What's motivation got to do with weight loss? 2Alperujo -- a beneficial complement in diet of dairy sheep during non-grazing periods 2
    ... for covering tissue sections and cell preparations immunohistochemically ... insoluble end products. UltraMount Plus can ... or AEC that require an aqueous mounting medium, ... No heating is required prior to use. This ...
    ... Intracellular (IC) Fixation Buffer, used in ... No. 00-8333), can be used to ... performing intracellular staining of cytokines and ... solutions have been specially formulated for ...
    Cytofix Buffer 100 mls...
    Cytofix/Cytoperm Plus Kit with GolgiPlug 250 Tests...
    Biology Products: